OncoPharm cover image

Mirvetuximab Soravtansine

OncoPharm

00:00

Adverse Events: Eye, Neuropathy, and Lab Effects

John asks what adverse events occur and summarizes rates of ocular events, peripheral neuropathy, nausea, AST elevations, and hematologic toxicity.

Play episode from 09:33
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app